77 related articles for article (PubMed ID: 34307128)
1. Efficacy and Safety of Transarterial Chemoembolization in Elderly Patients of Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Study.
Tang Q; Huang W; Liang J; Xue J
Front Oncol; 2021; 11():646410. PubMed ID: 34307128
[TBL] [Abstract][Full Text] [Related]
2. Comparison of drug-eluting bead with conventional transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: A randomized clinical trial.
Zhou TY; Tao GF; Zhou GH; Zhang YL; Zhu TY; Chen SQ; Wang HL; Wang BQ; Jing L; Chen F
Int J Surg; 2024 May; ():. PubMed ID: 38775550
[TBL] [Abstract][Full Text] [Related]
3. Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors Versus Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma with First- or Lower-Order Portal Vein Tumor Thrombosis.
Zhang JX; Cheng Y; Wei J; Fan WL; Liu J; Zhou CG; Liu S; Shi HB; Chu XY; Zheng WL; Zu QQ
Cardiovasc Intervent Radiol; 2024 Apr; ():. PubMed ID: 38671322
[TBL] [Abstract][Full Text] [Related]
4. Unleashing the potential: transarterial chemoembolization combined with intra-arterial infusion of bevacizumab for unresectable hepatocellular carcinoma.
Xie Q; Yang Y; Hao W; Luo C
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38801510
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib plus TACE with or without camrelizumab for the treatment of intermediate and advanced hepatocellular carcinoma.
Sun B; Chen L; Yu L; Zhang L; Sun T; Liu Y; Zheng C
Br J Radiol; 2024 May; ():. PubMed ID: 38711192
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma.
Wang YB; Zhang W; Bao L; Lu Y; Hong J
Wideochir Inne Tech Maloinwazyjne; 2023 Dec; 18(4):645-654. PubMed ID: 38239583
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Evaluation for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Patients Treated with Transarterial Chemoembolization Plus Molecular Targeted Therapies-Development and Validation of the ABPS Score.
Liu K; Zheng X; Dai J; Hou C; Lu D; Zhao B; Yin S; Wang G; Cao Q; Jiang B; Gao S; Huang X; Xie J; Zhang Y; Li S; Zhang A; Yang W; Wang S; Tan Y; Shi W; Lv W; Wu X
Acad Radiol; 2024 Mar; ():. PubMed ID: 38508935
[TBL] [Abstract][Full Text] [Related]
8. Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody.
Wang L; Feng JK; Lu CD; Wu JY; Zhou B; Wang K; Wei XB; Liang C; Zhou HK; Shi J; Guo WX; Lau WY; Yan ML; Cheng SQ
Oncologist; 2024 Mar; ():. PubMed ID: 38478404
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization for omental vein tumor thrombosis in hepatocellular carcinoma: a case report.
Hien PN; Chun HJ; Kim SH
J Gastrointest Oncol; 2024 Apr; 15(2):794-799. PubMed ID: 38756637
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study.
Ou X; Wu J; Wu J; Fu Y; Zeng Z; Li S; Li Y; Liu D; Li H; Li B; Zhou J; Zhuang S; Cheng S; Zhang Z; Wang K; Qu S; Yan M
Cancer Res Treat; 2024 Apr; ():. PubMed ID: 38697847
[TBL] [Abstract][Full Text] [Related]
11. Endoportal Radiofrequency Ablation and Stent Placement in Patients with Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma: A Study on Feasibility and Safety.
Mizandari M; Gotsiridze E; Keshavarz P; Nezami N; Azrumelashvili T; Nejati SF; Habib N; Chiang J; Raman SS
J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610893
[No Abstract] [Full Text] [Related]
12. Interventional therapy combined with tyrosine kinase inhibitors with or without immune checkpoint inhibitors as initial treatment for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis.
Du C; Wu H; Zhong T; Zhai Q; Yuan J; Peng J; Ma R; Li J
Discov Oncol; 2024 May; 15(1):164. PubMed ID: 38744743
[TBL] [Abstract][Full Text] [Related]
13. Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study.
Kudo M; Kang YK; Park JW; Qin S; Inaba Y; Assenat E; Umeyama Y; Lechuga MJ; Valota O; Fujii Y; Martini JF; Williams JA; Obi S
Liver Cancer; 2018 May; 7(2):148-164. PubMed ID: 29888205
[TBL] [Abstract][Full Text] [Related]
14. Second-line treatment with nivolumab, cabozantinib, regorafenib, or best supportive care in patients with advanced hepatocellular carcinoma: analysis at a Hispanic-majority NCI-designated cancer center.
Xia J; Gelfond J; Arora SP
J Gastrointest Oncol; 2021 Dec; 12(6):2943-2951. PubMed ID: 35070420
[TBL] [Abstract][Full Text] [Related]
15. Role of Biobran (Arabinoxylan Rice Bran) on Patients with Advanced Stage Hepatocellular Carcinoma.
Ashrafujjaman M; Mahtab MA; Noor-E-Alam SM; Rahim MA; Das DC; Ahmed F; Mamun AA; Mahmud T; Mahmood T
Euroasian J Hepatogastroenterol; 2023; 13(2):84-88. PubMed ID: 38222955
[TBL] [Abstract][Full Text] [Related]
16. Combination of Sorafenib, Camrelizumab, Transcatheter Arterial Chemoembolization, and Stereotactic Body Radiation Therapy as a Novel Downstaging Strategy in Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Case Series Study.
Huang Y; Zhang Z; Liao W; Hu K; Wang Z
Front Oncol; 2021; 11():650394. PubMed ID: 34408974
[TBL] [Abstract][Full Text] [Related]
17. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
Liu BJ; Gao S; Zhu X; Guo JH; Kou FX; Liu SX; Zhang X; Wang XD; Cao G; Chen H; Liu P; Zhu LZ; Xu HF; Yang RJ
Biomed Res Int; 2021; 2021():6670367. PubMed ID: 34337041
[TBL] [Abstract][Full Text] [Related]
18. The immunological and metabolic landscape in primary and metastatic liver cancer.
Li X; Ramadori P; Pfister D; Seehawer M; Zender L; Heikenwalder M
Nat Rev Cancer; 2021 Sep; 21(9):541-557. PubMed ID: 34326518
[TBL] [Abstract][Full Text] [Related]
19. Boosted-Dose Yttrium-90 Radiation Segmentectomy or Lobectomy for Hepatocellular Carcinoma Refractory to Prior Transarterial Embolization or Chemoembolization: A Single Institution Retrospective Case Series.
Srinivas S; Rose SC; Al Jammal O; Hsieh LJ; Rockwell HD; Duncan DP; Minocha J; Berman ZT
Cardiovasc Intervent Radiol; 2023 Apr; 46(4):460-469. PubMed ID: 36854903
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world.
Feng JK; Liu ZH; Fu ZG; Chai ZT; Sun JX; Wang K; Cheng YQ; Zhu HF; Xiang YJ; Zhou LP; Shi J; Guo WX; Zhai J; Cheng SQ
Front Oncol; 2022; 12():954203. PubMed ID: 36505818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
